Exhaled carbon monoxide and nitric oxide in COPD

Area of Science:

• Pulmonary Medicine
• Biomarkers
• Oxidative Stress

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a significant health concern characterized by chronic airway inflammation and oxidative stress.
• Noninvasive methods for monitoring disease progression and treatment efficacy are crucial for managing COPD.

Purpose of the Study:

• To evaluate exhaled carbon monoxide (CO) and nitric oxide (NO) as potential noninvasive in vivo biomarkers of oxidative stress in patients with COPD.
• To assess the influence of smoking status on these exhaled biomarkers.

Main Methods:

• A single-center cross-sectional study was conducted.
• Participants included healthy nonsmokers, smokers, stable ex-smokers with COPD, and stable current smokers with COPD.
• Pulmonary function tests and measurements of exhaled CO and NO were performed.

Main Results:

• Exhaled CO levels were elevated in ex-smokers with COPD compared to healthy controls, and even higher in current smokers with COPD.
• Exhaled NO levels were significantly higher in ex-smokers with COPD than in healthy nonsmokers and current smokers with COPD.
• A negative correlation was observed between exhaled NO and FEV1 in both ex-smokers and current smokers with COPD.

Conclusions:

• Exhaled CO and NO show promise as noninvasive biomarkers for monitoring airway inflammation and oxidant stress in COPD ex-smokers.
• Cigarette smoking significantly affects exhaled CO and NO levels, potentially limiting their utility as biomarkers in active smokers.